InMed Pharmaceuticals
0 followers
INM
Performance
About InMed Pharmaceuticals
InMed Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1 and CB2 receptors. The company pursues programs in Alzheimer’s disease, ocular (including age-related macular degeneration) and dermatological indications, and operates BayMedica, a subsidiary specializing in rare cannabinoids and proprietary cannabinoid analogs. With a global manufacturing and development footprint, InMed positions itself as a leader in small molecule therapeutics and cannabinoid manufacturing. Headquartered in Vancouver, British Columbia, the company emphasizes research, development and commercialization of cannabinoid-based therapeutics.